How is the Stoke Therapeutics Inc today?

The Stoke Therapeutics Inc today is trading in the down by -5.07% at 9.54.

How has Stoke Therapeutics Inc performed historically?

The Stoke Therapeutics Inc is currently trading down -5.07% on an intraday basis in the past week the index rose 6.83%. The index has been up 9.15% in the past quarter and fell -40.75% in the past year. You can view this in the overview section.

What is Stoke Therapeutics Inc Annual Revenue?

Stoke Therapeutics Inc Annual Revenue rose 316.34%, in the last year to $36.56 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Stoke Therapeutics Inc Annual Net Profit?

Stoke Therapeutics Inc Annual Net Profit rose 15.01% in the last year to $88.98 M. Its sector's average net profit growth for the last fiscal year was -11.16%.

What is Stoke Therapeutics Inc Price to Earning Ratio?

Stoke Therapeutics Inc Price to Earning Ratio is 10.36, higher than its sector PE ratio of 4.39.

What is Stoke Therapeutics Inc Stock Price?

Stoke Therapeutics Inc Stock Price fell 40.75% and underperformed its sector by 51.57% in the past year.

What is Stoke Therapeutics Inc Quarterly Revenue?

Stoke Therapeutics Inc Quarterly Revenue rose 3,661.12% YoY to $158.57 M. Its sector's average revenue growth YoY for the quarter was 3.13%.

What is Stoke Therapeutics Inc Quarterly Net profit?

Stoke Therapeutics Inc Quarterly Net profit rose 527.99% YoY to $112.88 M. Its sector's average net profit growth YoY for the quarter was -200.49%.

What is Stoke Therapeutics Inc Debt to Equity Ratio?

Stoke Therapeutics Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Stoke Therapeutics Inc Return on Equity(ROE)?

Stoke Therapeutics Inc Return on Equity(ROE) for the last financial year was -45.8%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Stoke Therapeutics Inc Mutual Fund Holding?

Stoke Therapeutics Inc Mutual Fund Holding increased by 2.55% in the last quarter to 31.15.

What is Stoke Therapeutics Inc Promoter Share Holding?

Stoke Therapeutics Inc Promoter Share Holding increased by 0.13% in the most recent quarter to 1.96%.

What is Stoke Therapeutics Inc Institutional Holding?

Stoke Therapeutics Inc Institutional Holding increased by 5.41% in the last quarter to 108.24.

Stoke Therapeutics Inc XNAS: STOK

Stoke Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Stoke Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Stoke Therapeutics Inc
Rating: 2.351152625
Author: Trendlyne DVM scores

Mid-range Performer

about

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antis...

9.54 -0.51 (-5.07%)

45.73% Fall from 52W High

256.1K XNAS Volume

XNAS 21 May, 2025 2:14 PM (EDT)

Medium Financial Strength

44.4 / 100

Mid Valuation

49.3 / 100

Technically Neutral

49.9 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

1Yr Price target upside is 135%

8 analysts

Stoke Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Stoke Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antis...

45.73% Fall from 52W High

SWOT Analysis

Stoke Therapeutics Inc Live Price Chart

Stoke Therapeutics Inc FAQ

How is Stoke Therapeutics Inc today?

Stoke Therapeutics Inc today is trading in the red, and is down by -5.07% at 9.54.

How has Stoke Therapeutics Inc performed historically?

Stoke Therapeutics Inc is currently trading down -5.07% on an intraday basis. In the past week the stock rose 6.83%. stock has been up 9.15% in the past quarter and fell -40.75% in the past year. You can view this in the overview section.